Author | Cheryl Guttman Krader; Reviewed by Dr Andric C. Perez-Ortiz


Investigators explore pathogenic cytokines as biomarkers for DMO

Results of a study analysing cytokine levels in the aqueous humour and serum of patients with nonproliferative diabetic retinopathy with and without diabetic macular oedema support further research investigating transforming growth factor-β-induced Gene Human Clone 30 (BIGH3) as a potential biomarker for DMO.